Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 61-71

  De La Monte, Suzanne M ^a,b   Sohn, Yoon K ^a   Etienne, Dannie ^a   Kraft, Joanny ^a   Wands, Jack R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIC NUCLEOTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE; PROTEIN P53;

ALZHEIMER DISEASE; APOPTOSIS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELL TYPE; CEREBROVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DEMENTIA; ENZYME ACTIVITY; GENE EXPRESSION; GLIA CELL; HUMAN; HUMAN CELL; NERVE CELL PLASTICITY; SMOOTH MUSCLE RELAXATION; VASODILATATION;

EID: 0034059297     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06351.x     Document Type: Conference Paper

References (76)

1. 1. CRYSTAL, H.A., D.W. DICKSON, M.J. SLIWINSKI, R.B. LIPTON, E. GROBER, N.H. MARKS & P. ANTIS. 1993. Pathological markers associated with normal aging and dementia in the elderly. Ann. Neurol. 34: 566-573.
2. 2. DICKSON, D.W., P. DAVIES, C. BEVONA, H.K. VAN, S.M. FACTOR, E. GROBER, M.K. ARONSON & H.A. CRYSTAL. 1994. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol. (Berl.) 88: 212-221.
3. 3. FRISONI, G.B., A. BELTRAMELLO, G. BINETTI, A. BIANCHETTI, C. WEISS, A. SCURATTI & M. TRABUCCHI. 1995. Computed tomography in the detection of the vascular component in dementia. Gerontology 41: 121-128.
4. 4. DE LA TORRE, J. 1994. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci. Biobehav. Rev. 18: 397-401.
5. 5. INCE, P.G., F.K. MCARTHUR, E. BJERTNESS, A. TORVIK, J.M. CANDY & J.A. EDWARDSON. 1995. Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions. Dementia 6: 162-168.
6. 6. KAWAMURA, J., J.S. MEYER, Y. TERAYAMA & S. WEATHERS. 1992. Leuko-araiosis and cerebral hypoperfusion compared in elderly normals and Alzheimer's dementia. J. Am. Geriatr. Soc. 40: 375-380.
7. 7. NAGY, Z., M.M. ESIRI, K.A. JOBST, J.H. MORRIS, E.M. KING, B. MCDONALD, C. JOACHIM, S. LITCHFIELD, L. BARNETSON & A.D. SMITH. 1997. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56: 165-170.
8. 8. PASQUIER, F. & D. LEYS. 1997. Why are stroke patients prone to develop dementia? J. Neurol. 244: 135-142.
9. 9. SNOWDON, D.A., L.H. GREINER, J.A. MORTIMER, K.P. RILEY, P.A. GREINER & W.R. MARKESBERY. 1997. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study [see comments]. JAMA 277: 813-817.
10. 10. VICTOROFF, J., W.J. MACK, S.A. LYNESS & H.C. CHUI. 1995. Multicenter clinicopathological correlation in dementia. Am. J. Psychiatry 152: 1476-1484.
11. 11. ZAHNER, B., C.J. LANG, A. ENGELHARDT, P. THIERAUF & B. NEUNDORFER. 1995. A case of Alzheimer's disease with extensive focal white matter changes. Dementia 6: 294-300.
12. 12. ETIENE, D., J. KRAFT, N. GANJU, T. GOMEZ-ISLA, B. GEMELLI, B.T. HYMAN, E.T. HEDLEY-WHYTE, J.R. WANDS & S.M. DE LA MONTE. 1998. Cerebrovascular pathology contributes to the heterogeneity of Alzheimer's disease. J. Alzheimer Dis. 1: 48-56.
13. 13. TOMIMOTO, H., I. AKIGUCHI, T. SUENAGA, M. NISHIMURA, H. WAKITA, S. NAKAMURA & J. KIMURA. 1996. Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients [see comments]. Stroke 27: 2069-2074.
14. 14. TOMIMOTO, H., I. AKIGUCHI, H. WAKITA, T. SUENAGA, S. NAKAMURA & J. KIMURA. 1997. Regressive changes of astroglia in white matter lesions in cerebrovascular disease and Alzheimer's disease patients. Acta Neuropathol. (Berl.). 94: 146-152.
15. 15. LOPEZ, O.L., B.S. RABIN, F.J. HUFF, D. REZEK & O.M. REINMUTH. 1992. Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjects. Stroke 23: 1078-1083.
16. 16. NAGATA, K., R.J. BUCHAN, E. YOKOYAMA, Y. KONDOH, M. SATO, H. TERASHI, Y. SATOH, Y. WATAHIKI, M. SENOVA, Y. HIRATA & J. HATAZAWA. 1997. Misery perfusion with preserved vascular reactivity in Alzheimer's disease. Ann. N.Y. Acad. Sci. 826: 272-281.
17. 17. TOHGI, H., H. YONEZAWA, S. TAKAHASHI, N. SATO, E. KATO, M. KUDO, K. HATANO & T. SASAKI. 1998. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology 40: 131-137.
18. 18. OLICHNEY, J.M., L.A. HANSEN, C.R. HOFSTETTER, M. GRUNDMAN, R. KATZMAN & L.J. THAL. 1995. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch. Neurol. 52: 702-708.
19. 19. VAN NOSTRAND, W.E., S.J. DAVIS & I.S. SAPORITO. 1996. Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders. Ann. N.Y. Acad. Sci. 777: 297-302.
20. 20. THOMAS, T., G. THOMAS, C. MCLENDON, T. SUTTON & M. MULLAN. 1996. beta-Amyloid-mediated vasoactivity and vascular endothelial damage [see comments]. Nature 380: 168-171.
21. 21. THOMAS, T., E.T. SUTTON, M.W. BRYANT & J.A. RHODIN. 1997. In vivo vascular damage, leukocyte activation and inflammatory response induced by beta-amyloid. J. Submicrosc. Cytol. Pathol. 29: 293-304.
22. 22. HAASE, J., P. HALAMA & R. HORR. 1996. [Effectiveness of brief infusions with Ginkgo biloba special extract EGb 761 in dementia of the vascular and Alzheimer type]. Z. Gerontol. Geriatr. 29: 302-309.
23. 23. HORR, R. & M. KIESER. 1998. [Ginkgo biloba special extract EGb 761-an anti-dementia drug]. Fortschr. Med. 116: 39-40.
24. 24. KANOWSKI, S., W.M. HERRMANN, K. STEPHAN, W. WIERICH & R. HORR. 1996. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29: 47-56.
25. 25. LE BARS, P.L., M.M. KATZ, N. BERMAN, T.M. ITIL, A.M. FREEDMAN & A.F. SCHATZBERG. 1997. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group [see comments]. JAMA 278: 1327-1332.
26. 26. SCHMIDT, H. & U. WALTER. 1994. NO at work. Cell 78: 919-925.
27. 27. BREDT, D. & S. SNYDER. 1994. Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium. Neuron 13: 301-313.
28. 28. KLATT, P., K. SCHMIDT, G. URAY & B. MAYER. 1993. Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor requirement, and the role of Nw-hydroxy-L-arginine as an intermediate. J. Biol. Chem. 268: 14781-14787.
29. 29. DINERMAN, J., T. DAWSON, M. SCHELL, A. SNOWMAN & S. SNYDER. 1994. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. Natl. Acad. Sci. USA 91: 4214-4218.
30. 30. BOJE, K. & P. ARORA. 1992. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587: 250-256.
31. 31. KOPROWSKI, H., Y. ZHENG, E. HEBER-KATZ, N. FRASER, L. RORKE, A. FU, C. HANLON & B. DIETZXCHOLD. 1993. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90: 3024-3027.
32. 32. MERRILL, J., L. IGNARRO, M. SHERMAN, J. MELINEK & T. LANE. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151: 2132-2141.
33. 33. VODOVOTZ, Y., M. LUCIA, K. FLANDERS, L. CHESTER, Q. XIE, T. SMITH, J. WEIDNER, R. MUMFORD, R. WEBBER, C. NATHAN, A. ROBERTS, C. LIPPA & M. SPORN. 1996. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184: 1425-1433.
34. 34. XIA, Y., V. DAWSON, T. DAWSON, S. SNYDER & J. ZWEIER. 1996. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. USA 93: 6770-6774.
35. 35. LIPTON, S., Y. CHOI, Z. PAN, S. LEIN, H. CHEN, N. SUCHER, J. LOSCALZO, D. SINGLE & J. STAMLER. 1993. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364: 626-632.
36. 36. LEIST, M., E. FAVA, C. MONTECUCCO & P. NICOTERA. 1997. Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur. J. Neurosci. 9: 1488-1498.
37. 37. STAMLER, J. 1994. Nitration and related target interactions of nitric oxide [review]. Cell 78: 931-936.
38. 38. POU, S., W. POU, D. BREDT, S. SNYDER & G. ROSEN. 1992. Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267: 24173-24176.
39. 39. CULCASI, M., M. LAFON-CAZAL, S. PIETRI & J. BOCKAERT. 1994. Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons. J. Biol. Chem. 269: 12589-12593.
40. 40. WOLF, G., G. HENSCHKE & S. WURDIG. 1993. Glutamate agonist-induced hippocampal lesion and nitric oxide synthase/NADPH-diaphorase: a light and electron microscopical study in the rat. Neurosci. Lett. 161: 49-52.
41. 41. HUANG, A., P. HUANG, N. PANAHIAN, T. DALKARA, M. FISHMAN & M. MOSKOWITZ. 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265: 1883-1885.
42. 42. NORRIS, P., H. WALDVOGEL, R. FAULL, D. LOVE & P. EMSON. 1996. Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striaturn of Huntington's disease. Neuroscience 72: 1037-1047.
43. 43. OURY, T., C. PIANTADOSI & J. CRAPO. 1993. Cold-induced brain edema in mice: involvement of extracellular superoxide dismutase and nitric oxide. J. Biol. Chem. 268: 15394-15398.
44. 44. ZHENG, Y., M.-H. SCHAFER, E. WEIHE, H. SHENG, S. CORISEDO, Z. FU, H. KOPROWSKI & B. DIETZSCHOLD. 1993. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlated with induction of nitric oxide synthase. J. Virol. 67: 5786-5791.
45. 45. HOOPER, D., O. BAGASRA, J. MARINI, A. ZBOREK, S. OHNISHI, R. KEAN, J. CHAMPION, A. SARKER, L. BOBROSKI, J. FARBERT, T. AKAIKE, H. MAEDA & H. KOPROWSKI. 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA 94: 2528-2533.
46. 46. WU, W., F. LIUZZI, F. SCHINCO, A. DEPTO, Y. LI, J. MONG, T. DAWSON & S. SNYDER. 1994. Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury. Neuroscience 61: 719-726.
47. 47. HESS, D., S. PATTERSON, D. SMITH & J. SKENE. 1994. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 366: 562-565.
48. 48. MESENGE, C., C. VERRECCHIA, M. ALLIX, R. BOULU & M. PLOTKINE. 1996. Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J. Neurotrauma 13: 11-16.
49. 49. NISHIKAWA, T., J. KIRSCH, R. KOEHLER, D. BREDT, S. SNYDER & R. TRAYSTMANN. 1993. Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats. Stroke 24: 1717-1724.
50. 50. GRISCAVAGE, J., J. FUKUTO, Y. KOMORI & L. IGNARRO. 1994. Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. Role of tetrahydrobiopterin in modulating the inhibitory action of nitric oxide. J. Biol. Chem. 269: 21644-21649.
51. 51. OSGAWA, N. 1994. Free radicals and neural cell damage. Rinsho Shinkeigaku 34: 1266-1268.
52. 52. NOVIKOV, L., L. NOVIKOVA & J. KELLERTH. 1995. Brain-derived neurotrophic factor promotes survival and blocks nitric oxide synthase experession in adult rat spinal motoneurons after ventral root avulsion. Neurosci. Lett. 200: 45-48.
53. 53. LI, L., W. WU, L. LIN, M. LEI, R. OPPENHEIM & L. HOUENOU. 1995. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92: 9771-9775.
54. 54. DAWSON, V., V. KIZUSHI, P. HUANG, S. SNYDER & T. DAWSON. 1996. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16: 2479-2487.
55. 55. FERRIERO, D., D. HOLTZMAN, S. BLACK & R. SHELDON. 1996. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol. Dis. 3: 64-71.
56. 56. NOWICKY, A. & L. BINDMAN. 1993. The nitric oxide synthase inhibitor, N-monomethyl-L-arginine blocks induction of a long-term potentiation-like phenomenon in rat medial frontal cortical neurons in vitro. J. Neurophysiol. 70: 1255-1259.
57. 57. PEUNOVA, N. & G. ENIKOLOPOV. 1995. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375: 68-73.
58. 58. FARINELLI, S., D. PARK & L. GREENE. 1996. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J. Neurosci. 16: 2325-2334.
59. 59. WARD, S., C. SHUTTLEWORTH & J. KENYON. 1994. Dorsal root ganglion neurons of embryonic chicks contain nitric oxide synthase and respond to nitric oxide. Brain Res. 648: 249-258.
60. 60. YEZIERSKI, R., S. LIU, G. RUENES, R. BUSTO & W. DIETRICH. 1996. Neuronal damage following intraspinal injection of a nitric oxide synthase inhibitor in the rat. J. Cereb. Blood Flow Metab. 16: 996-1004.
61. 61. DE LA MONTE, S.M., Y.K. SOHN, N. GANJU & J.R. WANDS. 1998. p53-and CD95-associated apoptosis in neurodegenerative diseases. Lab. Invest. 158: 1001-1009.
62. 62. DE LA MONTE, S.M., Y.K. SOHN & J.R. WANDS. 1997. Correlates of p53-and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. 152: 73-83.
63. 63. SU, J.H., G. DENG & C.W. COTMAN. 1997. Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression, and brain pathology. J. Neuropathol. Exp. Neurol. 56: 86-93.
64. 64. SOHN, Y.K., N. GANJU, K.D. BLOCK, J.R. WANDS & S.M. DE LA MONTE. 1999. Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases. J. Neurol. Sci. 162: 133-151.
65. 65. DE LA MONTE, S. & K. BLOCH. 1997. Aberrant expression of the constitutive endothelial nitric oxide synthase gene in Alzheimer's disease. Mol. Chem. Neuropathol. 30: 139-159.
66. 66. NOBLE, M. 1994. The O-2A lineage: from rats to humans. Recent Res. Cancer Res. 145: 67-75.
67. 67. RAFF, M., E. ABNEY, J. COHEN, R. LINDSAY & M. NOBLE. 1983. Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J. Neurosci. 3: 1289-1300.
68. 2+/calmodulin dependent nitric oxide synthase and a soluble guanylyl cyclase in vertebrate photoreceptor cells. EMBO J. 13: 3312-3320.
69. 69. BANI, D., P. FAILLI, M.G. BELLO, C. THIEMERMANN, T. BANI SACCHI, M. BIGAZZI & E. MASINI. 1998. Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture. Hypertension 31: 1240-1247.
70. 70. BERK, B.C., M.A. CORSON, T.E. PETERSON & H. TSENG. 1995. Protein kinases as mediators of fluid shear stress stimulated signal transduction in endothelial cells: a hypothesis for calcium-dependent and calcium-independent events activated by flow. J. Biomech. 28: 1439-1450.
71. 71. WU, H.M., Y. YUAN, D.C. ZAWIEJA, J. TINSLEY & H.J. GRANGER. 1999. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am. J. Physiol. 276: H535-H542.
72. 72. SUTTORP, N., S. HIPPENSTIEL, M. FUHRMANN, M. KRULL & T. PODZUWEIT. 1996. Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability. Am. J. Physiol. 270: C778-785.
73. 73. YUAN, Y., H.J. GRANGER, D.C. ZAWIEJA, D.V. DEFILY & W.M. CHILIAN. 1993. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am. J. Physiol. 264: H1734-H1739.
74. 74. POEGGEL, G., M. MULLER, I. SEIDEL, L. RECHARDT & H.G. BERNSTEIN. 1992. Histochemistry of guanylate cyclase, phosphodiesterase, and NADPH-diaphorase (nitric oxide synthase) in rat brain vasculature. J. Cardiovasc. Pharmacol. 20: S76-S79.
75. 75. SANCHEZ, L.S., S.M. DE LA MONTE, G. FILIPPOV, R.C. JONES, W.M. ZAPOL & K.D. BLOCH. 1998. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development. Pediatr. Res. 43: 163-168.
76. 76. CHICHE, J.D., S.M. SCHLUTSMEYER, D.B. BLOCH, S.M. DE LA MONTE, J.D. ROBERTS, JR., G. FILIPPOV, S.P. JANSSENS, A. ROSENZWEIG & K.D. BLOCH. 1998. Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide/cGMP. J. Biol. Chem. 273: 34263-34271.